(PharmaNewsWire.Com, August 29, 2017 ) Cancer is a chronic disease and is affecting a huge population. Many technologies are emerging in the cancer diagnostics market. This report is focused on emerging cancer diagnostics market specifically on biomarker tumor test. The market growth is propelled due to factors such as: increasing number of cancer cases, technological innovation and advancements, increasing awareness among people, and medicare & reimbursement policies, among others.
This study includes an overview and analysis of the emerging cancer diagnostics market, by test type, applications, and geography, allowing the research to develop a comprehensive outlook of the market. The market report presents a detailed and analytical study of the entire market and provides a comprehensive insight into various forms of developments, trends and key participants. The type of cancer, their incidence and prevalence rate has been discussed in the report. All of the above mentioned report coverage parameters are discussed across different regions such as North America, Europe, Asia Pacific (APAC) , and Rest of the World (ROW) . While highlighting the key driving and restraining forces for this dynamic market, the report also provides a comprehensive section of the prominent consortiums, associations, and regulatory bodies, and their involvement in the emerging cancer diagnostics market. The answers to the following key questions can be found in the report:-What are the major drivers, challenges and opportunities of the tumor biomarker test market and their use cases?-How is the tumor biomarker test market evolving?-What are the market shares of the leading segments of the tumor biomarker test market in 2015?-How will each test of the tumor biomarker test grow over the forecast period and how much revenue will these account for in 2023?-How will the market shares of the leading national markets change by 2023 and which country will lead the market in 2023?-How the industry will evolve during the forecast period between 2016 and 2023?-What are the key developmental strategies implemented in different applications across all regions?-How will the key market players leverage on key developments such as mergers & acquisitions, partnerships, and product launches among others?-Which geographical region will lead the global tumor biomarker test market by the end of the forecast period?-Who are the key players in the tumor biomarker test market?-What are different application in this market and how are they categorized?-What are the market trends and key developments in different geographical regions?-What are all market available cancer biomarker test?-What is the current market size and future projection for emerging cancer technologies in the major countries?-What are the key sources of information about emerging cancer technologies?-What is the incidence rate of major cancer type? The research study tries to answer various aspects of the emerging cancer diagnostics market with the help of central factors driving the market, threats that can possibly slow down the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The study takes into account Porter's Five Force model and opportunity matrix for an in-depth study of the emerging cancer diagnostics market and an assessment of the factors governing the same.
Table of Contents Executive Summary 18 1 The Research Scope and Methodology 25 1.1 Scope of the Report 25 1.2 Global Emerging Cancer Diagnostics Market Research Methodology 27 2 Introduction to Global Emerging Cancer Diagnostics Market 33 2.1 Overview 33 2.2 Analysis of Lifestyle Factors 33 2.2.1 Obesity/Weight 33 2.2.2 Physical Activity 35 2.2.3 Food Habits 36 2.2.4 Alcohol & Cancer 37 2.2.4.1 Countries with Highest Consumption of Alcoholic Drinks 37 2.2.5 Salt Consumption 38 2.2.6 Breastfeeding 40 2.3 High and Low Developed Countries 40 2.3.1 Men 41 2.3.2 Women 43 2.4 Data for Cancer Frequency by Country 44 2.4.1 Men 48 2.4.2 Women 50 2.5 Worldwide Cancer Data 53 2.5.1 Men 55 2.5.2 Women 56 3 Market Dynamics 62 3.1 Market Drivers 63 3.1.1 Increase in Prevalence Rate of Cancer 63 3.1.2 Increase in Sedentary Lifestyles 64 3.1.3 Robust Technological Advancement 65 3.1.4 Environmental Hazards 66 3.1.4.1 Five Primary Categories of Carcinogens are: - 67 3.1.5 Government Initiatives and Investment 67 3.2 Market Challenges 68 3.2.1 High Capital Investment 68 3.2.2 Dearth of Skilled Professionals 68 3.2.3 Lack of Awareness 69 3.3 Market Opportunities 70 3.3.1 Nanotechnology Applications in Cancer 70 3.3.2 3D Printing in Cancer Diagnostics 70 3.3.3 Robotics in Cancer Diagnostics and Treatment 71 3.3.4 Fluid Biopsy 71 3.3.5 Real Time Cancer Diagnostic iKnife 71 4 Competitive Insights 72 4.1 Key Market Developments & Strategies 72 4.1.1 Product Launch and Development 74 4.1.2 Collaborations, Joint Ventures & Partnerships 80 4.1.3 Business Expansion and Contracts 90 4.1.4 Patents, Approvals and Certifications 92 4.1.5 Mergers and Acquisitions 95 4.1.6 Other Strategies 100 4.2 Industry Attractiveness 102 4.3 Global Market Share Analysis 108 4.3.1 Market Share Analysis 108 5 Industry Analysis 110 5.1 Patent Analysis 110 5.2 Consortiums, Associations and Regulatory Bodies 125 6 Global Emerging Cancer Diagnostics (Tumor Biomarker Test) Market, Analysis and Forecast 138 6.1 Assumptions & Limitations for Analysis and Forecast 138 6.2 Market Overview 139 6.3 Global Emerging Cancer Diagnostics Market by Tumor Biomarker Test 141 6.3.1 Prostate Specific Antigen Tests 144 6.3.2 CTC Tests 147 6.3.3 Alpha-Fetoprotein (AFP) Tests 150 6.3.4 CA Test 152 6.3.4.1 CA 19-9 Tests 153 6.3.4.2 CA 125 Tests 154 6.3.5 HER2 Tests 155 6.3.6 BRCA Test 157 6.3.7 Anaplastic Lymphoma Kinase (ALK) Tests 159 6.3.8 EGFR Mutation Tests 160 6.3.9 KRAS Test 163 6.3.10 Others 164 6.3.10.1 National Rental Affordability Scheme (NRAS) Testing 164 6.3.10.2 RET Gene Testing 166 6.3.10.3 ROS Testing 167 6.3.10.4 PIK3CA Tests 168 6.4 Global Emerging Cancer Diagnostics Market by Application 170 6.4.1 Lung Cancer 171 6.4.2 Breast Cancer 176 6.4.3 Colorectal 180 6.4.4 Prostate Cancer 184 6.4.5 Blood Cancer 188 6.4.5.1 Leukaemia 189 6.4.5.2 Lymphoma 190 6.4.5.3 Myeloma 192 6.4.6 Others 196 6.5 Global Emerging Technologies in Cancer Diagnostics Market by Geography 207 6.5.1 North America 208 6.5.1.1 Country Analysis 210 6.5.1.1.1 U.S. 210 6.5.1.1.2 Canada 212 6.5.2 Europe 215 6.5.2.1 Countries Having the Highest Cancer Rates 216 6.5.2.2 Germany 217 6.5.2.3 France 219 6.5.2.4 The U.K. 222 6.5.2.5 Denmark 225 6.5.2.6 Belgium 228 6.5.2.7 Norway 229 6.5.3 APAC 231 6.5.3.1 India 235 6.5.3.2 China 238 6.5.3.3 Japan 239 6.5.3.4 Australia 243 6.5.3.5 Singapore 244 6.5.3.6 Others APAC Region 246 6.5.4 Rest of the World 246 6.5.4.1 Middle East 246 6.5.4.2 Africa 248 6.5.4.3 South America 249
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
